SCHEMBL6686573

SCHEMBL6686573

COC(=O)c1cccc2c(C)c(C)[nH]c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.51
NR4A2 P43354 4/20 0.51
PIM1 P11309 1/20 0.51
PIM3 Q86V86 1/20 0.51
MAPT P10636 4/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
NPC1 O15118 1/20 0.46
MAPK1 P28482 1/20 0.46
ALDH1A1 P00352 3/20 0.46
LMNA P02545 3/20 0.46
KDM4E B2RXH2 3/20 0.46
HPGD P15428 2/20 0.46
HTT P42858 2/20 0.46
HSD17B10 Q99714 2/20 0.46
TSHR P16473 2/20 0.44
POLB P06746 2/20 0.44
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.44
RECQL P46063 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17798406 0.84 PIM1 (0.49) NR4A2PIM1PIM3MAPTL3MBTL1
SCHEMBL6691799 0.81 AHR (0.56) AHRNR4A2PIM1MAPTL3MBTL1
SCHEMBL10201987 0.81 AHR (0.56) AHRPIM1MAPTL3MBTL1NPC1
SCHEMBL31175276 0.81 AHR (0.56) AHRNR4A2PIM1MAPTL3MBTL1
SCHEMBL9485757 0.77 MPL (0.61) NR4A2PIM1PIM3MAPTMAPK1
SCHEMBL17798493 0.76 PIM1 (0.42) NR4A2PIM1PIM3MAPTL3MBTL1
SCHEMBL6625709 0.75 NR4A2 (0.56) NR4A2PIM1PIM3MAPTNPC1
SCHEMBL3511612 0.74 LMNA (0.59) NR4A2MAPTALDH1A1LMNAKDM4E
SCHEMBL70429 0.74 LMNA (0.59) NR4A2MAPTALDH1A1LMNAKDM4E
SCHEMBL17798752 0.74 NR4A2 (0.68) NR4A2PIM1PIM3MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004063156-A1 NOVEL INDOLE DERIVATES AS FABP-4 INHIBITORS BIOVITRUM AB (SE) 2004-07-29 WO claimed
WO-2004063156-A1 NOVEL INDOLE DERIVATES AS FABP-4 INHIBITORS BIOVITRUM AB (SE) 2004-07-29 WO disclosed